First-in-Human Study of SRT-015 in Healthy Subjects.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is phase 1 first-in-human trial evaluating SRT-015 to assess safety, tolerability and pharmacokinetics. This study will be conducted in 3 parts - SAD, MAD and Food Effect with target of 96 healthy volunteers. This will be a single center, Phase 1, randomized, double-blind, placebo controlled, SAD and MAD study of dose escalation cohorts evaluating administration of SRT-015 or placebo. Additionally, PK will be assessed in fed and fasting states.
Epistemonikos ID: 8e638b3986e6a406ee9ea9248754bb7913e5ecd7
First added on: May 08, 2024